Tenon Medical (TNON) Fundamental Analysis: Revenue, Earnings & Valuation

0.87 / 10

Underperform

Fundamental rating is Underperform with a 0.9/10 score. Profit‑MV and Cash‑UP show slight strength, but Cash‑MV, ROE and other profitability metrics are deeply negative, indicating poor earnings quality and limited upside.

Analysis Checks(2/10)

ROA (%)

Value-96.23

Score0/3

Weight16.99%

1M Return-6.12%

Annualized return on equity (%)

Value-240.79

Score0/3

Weight16.24%

1M Return-5.73%

Profit-MV

Value0.41

Score2/3

Weight-15.53%

1M Return3.26%

Cash-UP

Value-0.01

Score2/3

Weight14.16%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-128.31

Score0/3

Weight16.99%

1M Return-6.12%

ROE (diluted) (%)

Value-202.67

Score0/3

Weight17.05%

1M Return-5.82%

Asset-MV

Value-0.48

Score1/3

Weight-2.94%

1M Return0.71%

ROE (%)

Value-180.59

Score0/3

Weight16.24%

1M Return-5.73%

Cash-MV

Value-0.09

Score1/3

Weight12.21%

1M Return-3.56%

Net profit / Total profit (%)

Value100.00

Score1/3

Weight8.59%

1M Return-2.37%

Is TNON undervalued or overvalued?

TNON scores 0.87/10 on fundamentals and holds a Premium valuation at present. Backed by its -180.59% ROE, -396.26% net margin, -0.66 P/E ratio, 1.76 P/B ratio, and 124.36% earnings growth, these metrics solidify its Underperform investment rating.